Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polly J Bingley

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 31, 2009
Clinical applications of diabetes antibody testingPolly J Bingley
Autoimmunity|November 3, 2004
Validation of autoantibody assays in type 1 diabetes: workshop programmePolly J Bingley, Alistair J K Williams
Diabetes|November 23, 2013
Islet autoantibody testing: an end to the trials and tribulations?Polly J Bingley, Alistair J K Williams
Diabetes|April 30, 2003
Diabetes Antibody Standardization Program: first assay proficiency evaluationPolly J Bingley, Ezio Bonifacio, Patricia W Mueller
Diabetologia|December 18, 2015
The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetesPolly J Bingley, David C Boulware, Jeffrey P Krischer, et al.
Clinical Endocrinology|May 3, 2006
IGF-secreting tumour treated with a combination of growth hormone and glucocorticoidsParth Narendran, Trevor Younger, Andrea Au-Yeung, et al.
Diabetes|January 5, 2002
High familial risk and genetic susceptibility in early onset childhood diabetesKathleen M Gillespie, Edwin A M Gale, Polly J Bingley
Diabetes Care|October 26, 2007
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)Polly J Bingley, Jeffrey L Mahon, Edwin A M Gale, et al.
Diabetes Care|September 20, 2011
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2βMichael Schlosser, Patricia W Mueller, Peter Achenbach, et al.
Journal of Immunological Methods|July 18, 2006
Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamineAlistair J K Williams, Alastair J Norcross, Kyla A Chandler, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|October 31, 2009
Clinical applications of diabetes antibody testingPolly J Bingley
Autoimmunity|November 3, 2004
Validation of autoantibody assays in type 1 diabetes: workshop programmePolly J Bingley, Alistair J K Williams
Diabetes|November 23, 2013
Islet autoantibody testing: an end to the trials and tribulations?Polly J Bingley, Alistair J K Williams
Diabetes|April 30, 2003
Diabetes Antibody Standardization Program: first assay proficiency evaluationPolly J Bingley, Ezio Bonifacio, Patricia W Mueller
Diabetologia|December 18, 2015
The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetesPolly J Bingley, David C Boulware, Jeffrey P Krischer, et al.
Clinical Endocrinology|May 3, 2006
IGF-secreting tumour treated with a combination of growth hormone and glucocorticoidsParth Narendran, Trevor Younger, Andrea Au-Yeung, et al.
Diabetes|January 5, 2002
High familial risk and genetic susceptibility in early onset childhood diabetesKathleen M Gillespie, Edwin A M Gale, Polly J Bingley
Diabetes Care|October 26, 2007
Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT)Polly J Bingley, Jeffrey L Mahon, Edwin A M Gale, et al.
Diabetes Care|September 20, 2011
Diabetes Antibody Standardization Program: First evaluation of assays for autoantibodies to IA-2βMichael Schlosser, Patricia W Mueller, Peter Achenbach, et al.
Journal of Immunological Methods|July 18, 2006
Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamineAlistair J K Williams, Alastair J Norcross, Kyla A Chandler, et al.
Pageof 6